APA (7th ed.) Citation

Budde, K., & Sommerer, C. (2015). Renal, efficacy and safety outcomes following late conversion of kidney transplant patients from calcineurin inhibitor therapy to everolimus: The randomized APOLLO study. Clinical nephrology, 83(1), . https://doi.org/10.5414/CN108444

Chicago Style (17th ed.) Citation

Budde, Klemens, and Claudia Sommerer. "Renal, Efficacy and Safety Outcomes Following Late Conversion of Kidney Transplant Patients from Calcineurin Inhibitor Therapy to Everolimus: The Randomized APOLLO Study." Clinical Nephrology 83, no. 1 (2015). https://doi.org/10.5414/CN108444.

MLA (9th ed.) Citation

Budde, Klemens, and Claudia Sommerer. "Renal, Efficacy and Safety Outcomes Following Late Conversion of Kidney Transplant Patients from Calcineurin Inhibitor Therapy to Everolimus: The Randomized APOLLO Study." Clinical Nephrology, vol. 83, no. 1, 2015, https://doi.org/10.5414/CN108444.